Rigel Pharmaceuticals
RIGL
#6821
Rank
NZ$1.05 B
Marketcap
NZ$57.97
Share price
-0.85%
Change (1 day)
52.59%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): NZ$0.20 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.28 Billion. In 2024 the company made an earning of NZ$43.71 Million, an increase over its 2023 earnings that were of -NZ$30.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.20 B372.37%
2024 NZ$43.71 M-244.27%
2023 -NZ$30.3 Million-66.79%
2022 -NZ$91.25 Million340.73%
2021 -NZ$20.71 Million-56.15%
2020 -NZ$47.22 Million-57.34%
2019 -NZ$0.12 Billion-7.66%
2018 -NZ$0.12 Billion-9.47%
2017 -NZ$0.14 Billion24.46%
2016 -NZ$0.11 Billion23.63%
2015 -NZ$86.05 Million-43.29%
2014 -NZ$0.16 Billion2.5%
2013 -NZ$0.15 Billion
2010 NZ$62.95 M-133.97%
2009 -NZ$0.19 Billion-18.49%
2008 -NZ$0.23 Billion71.91%
2007 -NZ$0.14 Billion84.74%
2006 -NZ$71.59 Million-10.17%
2005 -NZ$79.7 Million-15.73%
2004 -NZ$94.57 Million39.29%
2003 -NZ$67.9 Million10.3%
2002 -NZ$61.56 Million48.3%
2001 -NZ$41.52 Million-2.13%
2000 -NZ$42.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$13.70 B 6,662.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$21.76 B 10,637.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI
-NZ$0.22 Billion-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA